VolitionRX Limited (VNRX)
VolitionRx Limited Announces Inclusion of its Nu.Q® NETs Assay as Innovative Biomarker in Frances Real-World Evaluation of Early Detection of Sepsis
VolitionRx Limited Announces Inclusion of its Nu.Q® NETs Assay as Innovative Biomarker in Frances Real-World Evaluation of Early Detection of Sepsis
📈 **POSITIVE** • High confidence analysis (80%) • Strong positive clinical catalyst • Significant growth potential **Sentiment:** Positive (95%) **Content type:** Clinical